Nicolas Basse

1.0k total citations
18 papers, 775 citations indexed

About

Nicolas Basse is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Nicolas Basse has authored 18 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Oncology and 4 papers in Immunology. Recurrent topics in Nicolas Basse's work include Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Nicolas Basse is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (6 papers) and Glycosylation and Glycoproteins Research (4 papers). Nicolas Basse collaborates with scholars based in France, United Kingdom and Spain. Nicolas Basse's co-authors include Alan J. Warren, Michèle Reboud‐Ravaux, Trevor J. Rutherford, Joel L. Kaar, Andreas C. Joerger, Chi Chun Wong, Robert R. Kay, David Traynor, Joëlle Vidal and Xavier Maréchal and has published in prestigious journals such as Genes & Development, Blood and Journal of Medicinal Chemistry.

In The Last Decade

Nicolas Basse

18 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Basse France 13 565 259 194 143 73 18 775
James R. Hitchin United Kingdom 11 848 1.5× 189 0.7× 68 0.4× 91 0.6× 70 1.0× 19 1.0k
Nerea Gallastegui Germany 13 551 1.0× 238 0.9× 106 0.5× 31 0.2× 140 1.9× 15 745
Yeong Sang Kim United States 13 614 1.1× 179 0.7× 64 0.3× 134 0.9× 70 1.0× 17 863
John Douhan United States 13 407 0.7× 151 0.6× 79 0.4× 317 2.2× 169 2.3× 15 826
Kanda Sangthongpitag Singapore 15 629 1.1× 245 0.9× 48 0.2× 33 0.2× 76 1.0× 25 827
Weiwen Ying United States 16 658 1.2× 113 0.4× 74 0.4× 162 1.1× 188 2.6× 27 973
Rosalinda Syto United States 11 569 1.0× 320 1.2× 31 0.2× 144 1.0× 96 1.3× 16 809
Vanda Pogačić Switzerland 9 1.1k 2.0× 227 0.9× 55 0.3× 73 0.5× 149 2.0× 12 1.5k
Michael Fitzgerald United States 11 600 1.1× 293 1.1× 41 0.2× 164 1.1× 254 3.5× 17 1.0k
Stacey L. Hembruff United States 16 583 1.0× 351 1.4× 47 0.2× 99 0.7× 16 0.2× 23 890

Countries citing papers authored by Nicolas Basse

Since Specialization
Citations

This map shows the geographic impact of Nicolas Basse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Basse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Basse more than expected).

Fields of papers citing papers by Nicolas Basse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Basse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Basse. The network helps show where Nicolas Basse may publish in the future.

Co-authorship network of co-authors of Nicolas Basse

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Basse. A scholar is included among the top collaborators of Nicolas Basse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Basse. Nicolas Basse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Erb, Stéphane, Renaud Morales, Guilhem Chaubet, et al.. (2024). Targeted delivery of immune-stimulating bispecific RNA, inducing apoptosis and anti-tumor immunity in cancer cells. iScience. 27(3). 109068–109068. 5 indexed citations
2.
Erb, Stéphane, et al.. (2024). Protocol to generate, purify, and analyze antibody-oligonucleotide conjugates from off-the-shelf antibodies. STAR Protocols. 5(4). 103329–103329. 2 indexed citations
3.
Bärenz, Felix, et al.. (2021). Discovery and Optimization of a Series of Benzofuran Selective ERAP1 Inhibitors: Biochemical and In Silico Studies. ACS Medicinal Chemistry Letters. 12(7). 1137–1142. 5 indexed citations
4.
Lai, Lo, Kanika Sharma, N. Muzet, et al.. (2021). Sensitivity of Oncogenic KRAS-Expressing Cells to CDK9 Inhibition. SLAS DISCOVERY. 26(7). 922–932. 1 indexed citations
5.
Maréchal, Xavier, Emilie Génin, Lixian Qin, et al.. (2013). 1,2,4-Oxadiazoles Identified by Virtual Screening and their Non-Covalent Inhibition of the Human 20S Proteasome. Current Medicinal Chemistry. 20(18). 2351–2362. 22 indexed citations
6.
Maréchal, Xavier, Nicolas Richy, Emilie Génin, et al.. (2012). Noncovalent inhibition of 20S proteasome by pegylated dimerized inhibitors. European Journal of Medicinal Chemistry. 52. 322–327. 18 indexed citations
7.
Wong, Chi Chun, David Traynor, Nicolas Basse, Robert R. Kay, & Alan J. Warren. (2011). Defective ribosome assembly in Shwachman-Diamond syndrome. Blood. 118(16). 4305–4312. 120 indexed citations
8.
Finch, Andrew J., Christine Hilcenko, Nicolas Basse, et al.. (2011). 38 Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Leukemia Research. 35. S13–S13. 18 indexed citations
9.
Finch, Andrew J., Christine Hilcenko, Nicolas Basse, et al.. (2011). Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes & Development. 25(9). 917–929. 200 indexed citations
10.
Basse, Nicolas, Joel L. Kaar, Giovanni Settanni, et al.. (2010). Toward the Rational Design of p53-Stabilizing Drugs: Probing the Surface of the Oncogenic Y220C Mutant. Chemistry & Biology. 17(1). 46–56. 93 indexed citations
11.
Groll, M., Nerea Gallastegui, Xavier Maréchal, et al.. (2010). 20S Proteasome Inhibition: Designing Noncovalent Linear Peptide Mimics of the Natural Product TMC‐95A. ChemMedChem. 5(10). 1701–1705. 43 indexed citations
12.
Kaar, Joel L., Nicolas Basse, Andreas C. Joerger, et al.. (2010). Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding. Protein Science. 19(12). 2267–2278. 60 indexed citations
13.
Basse, Nicolas, et al.. (2009). Development of pseudopeptides and peptidomimetics as eukaryote proteasome inhibitors. Comptes Rendus Chimie. 12(10-11). 1163–1172. 2 indexed citations
14.
Basse, Nicolas, Matthieu Montès, Xavier Maréchal, et al.. (2009). Novel Organic Proteasome Inhibitors Identified by Virtual and in Vitro Screening. Journal of Medicinal Chemistry. 53(1). 509–513. 38 indexed citations
15.
Maréchal, Xavier, Nicolas Basse, Michelle Bouvier‐Durand, et al.. (2008). Novel fluorinated pseudopeptides as proteasome inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(1). 83–86. 31 indexed citations
16.
Bayot, Aurélien, Nicolas Basse, Irene Lee, et al.. (2007). Towards the control of intracellular protein turnover: Mitochondrial Lon protease inhibitors versus proteasome inhibitors. Biochimie. 90(2). 260–269. 47 indexed citations
17.
Basse, Nicolas, Sandrine Piguel, David Papapostolou, et al.. (2007). Linear TMC-95-Based Proteasome Inhibitors. Journal of Medicinal Chemistry. 50(12). 2842–2850. 54 indexed citations
18.
Basse, Nicolas, et al.. (2006). Development of lipopeptides for inhibiting 20S proteasomes. Bioorganic & Medicinal Chemistry Letters. 16(12). 3277–3281. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James R. Hitchin Breakdown of academic impact, for papers by Nerea Gallastegui Breakdown of academic impact, for papers by Yeong Sang Kim Breakdown of academic impact, for papers by John Douhan Breakdown of academic impact, for papers by Kanda Sangthongpitag Breakdown of academic impact, for papers by Weiwen Ying Breakdown of academic impact, for papers by Rosalinda Syto Breakdown of academic impact, for papers by Vanda Pogačić Breakdown of academic impact, for papers by Michael Fitzgerald Breakdown of academic impact, for papers by Stacey L. Hembruff
Rankless by CCL
2026